TEZEO HCT 40MG/12,5 MG TBL NOB 28

What is the maximum co-payment for TEZEO HCT?

If the insurance company contributes, the maximum co-payment is 255,67 Kč. The maximum pharmacy price is 316,63 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does TEZEO HCT have a counted co-payment set?

Yes, the medicine has a counted co-payment of 79,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

60,96 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe TEZEO HCT?

Prescription is not conditional on a medical specialization.

What is the composition of TEZEO HCT?

Telmisartan (40 mg), hydrochlorothiazid (12,5 mg), sorbitol, hydroxid sodný, povidon k 25, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to TEZEO HCT?

The medicine belongs to ATC group C09DA07 – TELMISARTAN A DIURETIKA. Medicines with the same active substance can be found here.

Who manufactures TEZEO HCT?

Zentiva, k.s., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 29. 5. 2024. Production was terminated with effect from 31. 7. 2024. The manufacturer lists medicines with the following code as a potential substitute: